The folding, misfolding, and degradation of membrane proteins is controlled by multiple processes within the cell. In this issue of Cell, Wang et al. (2006) present an interactome for CFTR, the chloride channel that is misfolded and prematurely degraded in cystic fibrosis. Among the proteins interacting with CFTR is a new member of the Hsp90 chaperone system, Aha1, that plays a central role in CFTR folding. 674 Cell 127, November 17, 2006 ©2006 Elsevier Inc. and interconnected subnetworks suggests that CFTR directly or indirectly impacts cellular processes that extend far beyond its role as an ion channel.
Protein folding in cells is facilitated by several elegant chaperone machines that improve folding efficiency and minimize the occurrence of misfolded proteins in a crowded macromolecular environment. The central components of these machines are finely tuned by regulators, or cochaperones, that balance the kinetic and thermodynamic constraints of client proteins and thus create an environment (termed folding solvent) to optimize correct folding (Kelly and Balch, 2006) . Many components of this system also recognize misfolded proteins and facilitate their degradation through the ubiquitin proteasome system. These competing pathways for protein maturation and degradation intersect in the endoplasmic reticulum (ER), where nearly a third of the cellular proteome is synthesized, folded, and packaged for transport (Younger et al., 2006) . In this issue, Wang et al., (2006) provide new insight into the complexity of protein networks that populate the secretory pathway. They identify new factors that govern the fate of the cystic fibrosis transmembrane conductance regulator (CFTR), an apical membrane ATP-regulated chloride channel whose misfolding is implicated in cystic fibrosis.
Cystic fibrosis is an inherited disease of epithelial tissues caused primarily by point mutations that disrupt CFTR folding and delivery to the plasma membrane (Cheng et al., 1990) . CFTR folding takes place in the ER and requires the precise organization of two transmembrane domains and three cytosolic domains prior to export (Xiong et al., 1997) . In most cells, this process is both complex and inefficient (ure 1). Degradation approaches 100% for the major disease-related mutant, ∆F508, which is found in more than 90% of individuals with cystic fibrosis. Once folded, however, ∆F508 CFTR can traffic to the plasma membrane and partially restore chloride transport. Thus, interventions that could restore ∆F508 folding are of major clinical interest. Wang et al., (2006) now address this problem using multidimensional protein identification technology (MudPIT) to identify nearly 200 proteins (the "interactome") from four different cell types that coimmunoprecipitate with either wild-type or ∆F508 CFTR. Some of these interactions were either known or predicted based on prior studies of CFTR stability, trafficking, and endocytosis. However, the largest group-more than two-thirds of the proteins identified-have no known function related to CFTR. Even though some known interactions were not identified in this screen, which indicates that the total interactome is not yet complete, these data provide a valuable starting point for further study. Notably, the presence of several elaborate
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One of the most interesting findings to emerge from this analysis is the extent to which CFTR associates with the cytosolic and lumenal folding machinery. Multiple chaperones, including calnexin, Hsp40, Hsp70, and Hsp90, were known to bind wild-type and mutant forms of CFTR. Although Hsp70 decreased aggregation of purified CFTR cytosolic domains in vitro, in cells it appeared to primarily inhibit surface expression of ∆F508 CFTR. By contrast, Hsp90 stimulated the maturation of ∆F508 CFTR in a manner analogous to its role in the activation of kinases and steroid hormone receptors (Loo et al., 1998; Wegele, et al., 2004) . Because the Hsp70 and Hsp90 systems are functionally linked by regulatory cochaperones that promote the exchange of the initial interaction with Hsp40/70 for cargo-specific Hsp90 folding complexes, early proposals suggested that the fate of CFTR in the ER might be controlled through a similar mechanism. This speculation was gradually substantiated by many groups who demonstrated that Hsp70 could promote either CFTR maturation or degradation, depending on the particular complement of cochaperones present (reviewed in Amaral, 2004) .
Wang and colleagues now identify 31 chaperones and cochaperones for CFTR, many of which preferentially bind to ∆F508. These chaperones and cochaperones were found to be associated with wild-type or ∆F508 CFTR stably expressed in baby hamster kidney (BHK) cells. The authors propose that these proteins comprise the minimal cellular folding environment, or "chaperome," that collectively determines whether ∆F508 CFTR achieves energetically favorable folding or is targeted for degradation. Detailed analysis of three cochaperones, p23, FKBP8, and Aha1, firmly places Hsp90 at this decision point (Figure 1 ). The cochaperone p23 inhibits Hsp90 ATPase activity, stimulates formation of the Hsp90 folding complex, and stabilizes Hsp90 binding to client proteins (Wegele et al., 2004) . Consistent with this, Wang et al. show that reduction of p23 levels in human embryonic kidney (HEK) cells increases degradation of ∆F508 CFTR, whereas overexpression prevents degradation but does not enhance trafficking. The simplest explanation is that reducing levels of p23 inhibits transfer to Hsp90 and thus shifts the balance of immature ∆F508 CFTR binding to favor Hsp70 complexes that subsequently recruit cofactors and promote degradation. Persistent Hsp90 binding in the presence of excess p23 might additionally sequester CFTR and prevent its packaging into COPII vesicles in the ER for export. Further analysis of how manipulating p23 expression affects the binding of chaperones to CFTR will be needed to determine whether this model is correct.
Of the purified cochaperones studied in detail, Aha1 mediated the most remarkable effects. Aha1 is a potent stimulator of figure 1. chaperones and cfTR folding A model depicts the chaperone-assisted pathway for the folding of CFTR (cystic fibrosis transmembrane conductance regulator). During CFTR synthesis, transmembrane domains are integrated into the endoplasmic reticulum (ER) membrane by the Sec61 translocon, and cytosolic/lumenal chaperones initiate binding to the nascent unfolded polypeptide. Deletion of Phe508 in the first nucleotide-binding domain (NBD1) is a common cause of cystic fibrosis. ATP-dependent Hsp40/70 cycling results in the recruitment of HOP, p50/Cdc37, and p23, which stimulate loading of client-specific Hsp90 complexes that facilitate maturation of the CFTR fold. Hsp90 ATPase activity and cycling is stimulated by Aha1, and late complexes are released to allow CFTR packaging into ER export vesicles. The stoichiometry, temporal recruitment, and displacement of chaperone complexes are not known. However, it is likely that the complement of cytosolic/lumenal chaperones is highly dynamic and evolves toward more mature Hsp90 complexes as folding proceeds. Failure of CFTR to achieve a stable fold (during Hsp70/90 cycling) tips the balance of this cellular program to favor the recruitment of cofactors that promote degradation. This results in CFTR polyubiquitination, membrane extraction, and degradation by VCP, proteasomes, and other membrane-bound and cytosolic components.
Hsp90 ATPase activity that acts as a late cofactor of the Hsp90 complex (Panaretou et al., 2002; Wegele et al., 2004) . Wang et al., (2006) show that overexpression of Aha1 markedly destabilized ∆F508 CFTR, whereas its downregulation significantly improved stability, trafficking, and delivery of functional ∆F508 CFTR to the plasma membrane. Reduction of Aha1 protein levels decreased ∆F508 CFTR binding to Hsp90 but did not appear to induce cellular stress or alter the levels of other chaperones. These findings are surprising for several reasons. First, Aha1 enhances ∆F508 CFTR degradation, whereas it has been shown to promote activation of other Hsp90 clients (Wegele et al., 2004) . Second, the downregulation of p23 destabilized ∆F508 CFTR despite predictions that p23 downregulation should also decrease CFTR binding to Hsp90. Although several scenarios could be envisioned, these data suggest that Aha1 blocks CFTR-Hsp90 interactions in a manner very different from p23 and that the outcome depends on where in the Hsp90 pathway these cofactors act. If p23 facilitates client transfer from the Hsp70 to the Hsp90 system as has been proposed, then less CFTR would be transferred to Hsp90 when p23 levels were reduced. In contrast, a reduction in Aha1 might induce late release of CFTR from the mature Hsp90 complex, perhaps after a transport-permissive conformation is achieved. One intriguing possibility is that decreasing the levels of Aha1 allows ∆F508 CFTR increased time to bypass a proposed kinetic block in folding (Qu et al., 1997) . A detailed understanding of the temporal recruitment of these and other cochaperones will be needed in order to determine how the balance of Aha1 and Hsp90 cycling perturbs the folding environment to favor ∆F508 maturation.
What is clear from these studies is that maturation of at least some proteins that are prone to misfolding can be enhanced by manipulation of both the Hsp70 and Hsp90 chaperone systems. For the moment, Wang et al., (2006) have focused attention on an important decision point that likely involves the handoff of client proteins from Hsp40/70 to the Hsp90 folding complex. The next challenge will be to determine which of the many newly implicated components of this network can be targeted to promote maturation of specific cargos with little cost in terms of toxicity to the cell. Such a strategy might be used in therapies for diseases associated with protein misfolding, including cystic fibrosis.
The tumor-suppressor protein p53 is a key regulator of cell-cycle control, apoptosis, and genomic stability. Under normal growth conditions, the stability of the p53 protein is tightly regulated. At least five ubiquitin ligases (E6-AP, Hdm2, Cop1, Pirh2, and ARF-BP1) have been shown to mediate ubiquitin-dependent proteasomal degradation of p53. Yet how these ligases are regulated and coordinated is unknown (Brooks and
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